Company registration number 13451980 (England and Wales)
JPR CLINICAL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2023
PAGES FOR FILING WITH REGISTRAR
JPR CLINICAL LIMITED
CONTENTS
Page
Balance sheet and notes to the financial statements
1 - 2
JPR CLINICAL LIMITED
BALANCE SHEET
AS AT
30 JUNE 2023
30 June 2023
- 1 -
2023
2022
£
£
£
£
Fixed assets
5,455
4,927
Current assets
128,040
63,427
Creditors: amounts falling due within one year
(39,666)
(15,075)
Net current assets
88,374
48,352
Total assets less current liabilities
93,829
53,279
Net assets
93,829
53,279
Capital and reserves
93,829
53,279
Notes to the financial statements
1
Directors' benefits: advances, credit and guarantees

During the year, the company advanced the director £13,919 (2022 - £7,026) and the director repaid the company £312 (2022 - £7,494). At the year end, the director owed the company £13,723 (2022 - £468 was owed to the director). All amounts have been advanced informally, interest has applied daily to the outstanding aggregate balance at the official rate and all individual advances are repayable on demand.

 

2
Employees

The average number of persons, including directors, employed by the company during the year was as follows:

2023
2022
Number
Number
Employees
2
2

JPR Clinical Limited is a private company limited by shares incorporated in England and Wales. The registered office is One St. Peter's Square, Manchester, M2 3DE.

For the year ended 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

JPR CLINICAL LIMITED
BALANCE SHEET (CONTINUED)
AS AT
30 JUNE 2023
30 June 2023
- 2 -

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 28 March 2024 and are signed on its behalf by:
J Ring
Director
Company registration number 13451980 (England and Wales)
2023-06-302022-07-01falseCCH SoftwareCCH Accounts Production 2023.300No description of principal activityJ RingJ Pricefalse134519802022-07-012023-06-30134519802023-06-30134519802022-06-3013451980core:CurrentFinancialInstrumentscore:WithinOneYear2023-06-3013451980core:CurrentFinancialInstrumentscore:WithinOneYear2022-06-3013451980bus:Director12022-07-012023-06-30134519802021-06-112022-06-3013451980bus:PrivateLimitedCompanyLtd2022-07-012023-06-3013451980bus:SmallCompaniesRegimeForAccounts2022-07-012023-06-3013451980bus:Micro-entities2022-07-012023-06-3013451980bus:AuditExemptWithAccountantsReport2022-07-012023-06-3013451980bus:Director22022-07-012023-06-3013451980bus:FullAccounts2022-07-012023-06-30xbrli:purexbrli:sharesiso4217:GBP